nodes	percent_of_prediction	percent_of_DWPC	metapath
Trazodone—HTR2C—choroid plexus—malignant glioma	0.0604	0.172	CbGeAlD
Trazodone—HTR2A—choroid plexus—malignant glioma	0.0303	0.0863	CbGeAlD
Trazodone—ORM1—vertebral column—malignant glioma	0.0237	0.0677	CbGeAlD
Trazodone—Tonic-clonic seizures—Carmustine—malignant glioma	0.019	0.0466	CcSEcCtD
Trazodone—HTR2C—telencephalic ventricle—malignant glioma	0.0177	0.0504	CbGeAlD
Trazodone—HTR2A—cerebellar cortex—malignant glioma	0.0153	0.0435	CbGeAlD
Trazodone—HTR1A—telencephalic ventricle—malignant glioma	0.0149	0.0424	CbGeAlD
Trazodone—Paranoid reaction—Carmustine—malignant glioma	0.012	0.0295	CcSEcCtD
Trazodone—HTR2A—pons—malignant glioma	0.0108	0.0307	CbGeAlD
Trazodone—Grand mal convulsion—Carmustine—malignant glioma	0.0108	0.0263	CcSEcCtD
Trazodone—HTR2A—vertebral column—malignant glioma	0.0107	0.0305	CbGeAlD
Trazodone—HTR2A—telencephalic ventricle—malignant glioma	0.00888	0.0253	CbGeAlD
Trazodone—Cerebration impaired—Temozolomide—malignant glioma	0.00841	0.0206	CcSEcCtD
Trazodone—Aphasia—Carmustine—malignant glioma	0.00789	0.0193	CcSEcCtD
Trazodone—Vilazodone—CYP2C18—malignant glioma	0.00778	0.292	CrCbGaD
Trazodone—HTR2A—pineal body—malignant glioma	0.0077	0.0219	CbGeAlD
Trazodone—Aphasia—Temozolomide—malignant glioma	0.00763	0.0187	CcSEcCtD
Trazodone—Hypokinesia—Carmustine—malignant glioma	0.00758	0.0186	CcSEcCtD
Trazodone—Paranoia—Carmustine—malignant glioma	0.00751	0.0184	CcSEcCtD
Trazodone—Stupor—Carmustine—malignant glioma	0.00686	0.0168	CcSEcCtD
Trazodone—Extrapyramidal disorder—Temozolomide—malignant glioma	0.00657	0.0161	CcSEcCtD
Trazodone—Cholestasis—Temozolomide—malignant glioma	0.00651	0.016	CcSEcCtD
Trazodone—Trifluoperazine—CALY—malignant glioma	0.00631	0.237	CrCbGaD
Trazodone—Memory impairment—Temozolomide—malignant glioma	0.0063	0.0154	CcSEcCtD
Trazodone—Speech disorder—Carmustine—malignant glioma	0.00595	0.0146	CcSEcCtD
Trazodone—Speech disorder—Temozolomide—malignant glioma	0.00575	0.0141	CcSEcCtD
Trazodone—Disturbance in attention—Temozolomide—malignant glioma	0.00571	0.014	CcSEcCtD
Trazodone—Leukocytosis—Carmustine—malignant glioma	0.00545	0.0133	CcSEcCtD
Trazodone—Hyperbilirubinaemia—Temozolomide—malignant glioma	0.00544	0.0133	CcSEcCtD
Trazodone—Clozapine—CALY—malignant glioma	0.00526	0.198	CrCbGaD
Trazodone—Gait disturbance—Carmustine—malignant glioma	0.00524	0.0128	CcSEcCtD
Trazodone—Coordination abnormal—Carmustine—malignant glioma	0.00521	0.0128	CcSEcCtD
Trazodone—Hearing impaired—Temozolomide—malignant glioma	0.0052	0.0127	CcSEcCtD
Trazodone—Gait disturbance—Temozolomide—malignant glioma	0.00507	0.0124	CcSEcCtD
Trazodone—Coordination abnormal—Temozolomide—malignant glioma	0.00504	0.0123	CcSEcCtD
Trazodone—Depressed level of consciousness—Carmustine—malignant glioma	0.00494	0.0121	CcSEcCtD
Trazodone—Urinary incontinence—Carmustine—malignant glioma	0.00494	0.0121	CcSEcCtD
Trazodone—HTR2C—brainstem—malignant glioma	0.00479	0.0136	CbGeAlD
Trazodone—Urinary incontinence—Temozolomide—malignant glioma	0.00478	0.0117	CcSEcCtD
Trazodone—Depressed level of consciousness—Temozolomide—malignant glioma	0.00478	0.0117	CcSEcCtD
Trazodone—HTR2A—endothelium—malignant glioma	0.00476	0.0136	CbGeAlD
Trazodone—Dry eye—Temozolomide—malignant glioma	0.00457	0.0112	CcSEcCtD
Trazodone—SLC6A4—brainstem—malignant glioma	0.00454	0.0129	CbGeAlD
Trazodone—Mental disability—Carmustine—malignant glioma	0.00444	0.0109	CcSEcCtD
Trazodone—HTR2A—blood vessel—malignant glioma	0.00439	0.0125	CbGeAlD
Trazodone—Mental disability—Temozolomide—malignant glioma	0.00429	0.0105	CcSEcCtD
Trazodone—HTR2C—telencephalon—malignant glioma	0.00425	0.0121	CbGeAlD
Trazodone—Eye pain—Carmustine—malignant glioma	0.00412	0.0101	CcSEcCtD
Trazodone—HTR1A—brainstem—malignant glioma	0.00403	0.0115	CbGeAlD
Trazodone—SLC6A4—telencephalon—malignant glioma	0.00403	0.0115	CbGeAlD
Trazodone—Deafness—Temozolomide—malignant glioma	0.00401	0.00983	CcSEcCtD
Trazodone—HTR2B—telencephalon—malignant glioma	0.00399	0.0114	CbGeAlD
Trazodone—Eye pain—Temozolomide—malignant glioma	0.00398	0.00975	CcSEcCtD
Trazodone—Amnesia—Carmustine—malignant glioma	0.00395	0.00969	CcSEcCtD
Trazodone—Nasal congestion—Temozolomide—malignant glioma	0.00394	0.00966	CcSEcCtD
Trazodone—Amnesia—Temozolomide—malignant glioma	0.00382	0.00936	CcSEcCtD
Trazodone—Hyponatraemia—Carmustine—malignant glioma	0.00373	0.00914	CcSEcCtD
Trazodone—Diplopia—Carmustine—malignant glioma	0.00372	0.0091	CcSEcCtD
Trazodone—ADRA1A—brainstem—malignant glioma	0.00372	0.0106	CbGeAlD
Trazodone—Diplopia—Temozolomide—malignant glioma	0.00359	0.0088	CcSEcCtD
Trazodone—HTR1A—telencephalon—malignant glioma	0.00358	0.0102	CbGeAlD
Trazodone—Ataxia—Carmustine—malignant glioma	0.00349	0.00856	CcSEcCtD
Trazodone—Ataxia—Temozolomide—malignant glioma	0.00338	0.00827	CcSEcCtD
Trazodone—HTR2C—medulla oblongata—malignant glioma	0.00334	0.00951	CbGeAlD
Trazodone—ORM1—spinal cord—malignant glioma	0.00331	0.00944	CbGeAlD
Trazodone—ADRA1A—telencephalon—malignant glioma	0.0033	0.00939	CbGeAlD
Trazodone—HTR2C—midbrain—malignant glioma	0.00305	0.00869	CbGeAlD
Trazodone—HTR2C—spinal cord—malignant glioma	0.00298	0.00848	CbGeAlD
Trazodone—SLC6A4—midbrain—malignant glioma	0.00289	0.00824	CbGeAlD
Trazodone—ABCB1—blood vessel—malignant glioma	0.00288	0.0082	CbGeAlD
Trazodone—Pollakiuria—Temozolomide—malignant glioma	0.00287	0.00702	CcSEcCtD
Trazodone—Erectile dysfunction—Temozolomide—malignant glioma	0.00286	0.007	CcSEcCtD
Trazodone—Photosensitivity reaction—Temozolomide—malignant glioma	0.00283	0.00694	CcSEcCtD
Trazodone—Weight increased—Temozolomide—malignant glioma	0.00282	0.00692	CcSEcCtD
Trazodone—SLC6A4—spinal cord—malignant glioma	0.00282	0.00804	CbGeAlD
Trazodone—Weight decreased—Temozolomide—malignant glioma	0.00281	0.00688	CcSEcCtD
Trazodone—ORM1—central nervous system—malignant glioma	0.00269	0.00766	CbGeAlD
Trazodone—HTR2A—embryo—malignant glioma	0.00262	0.00747	CbGeAlD
Trazodone—HTR1A—midbrain—malignant glioma	0.00257	0.00732	CbGeAlD
Trazodone—Hallucination—Carmustine—malignant glioma	0.00256	0.00627	CcSEcCtD
Trazodone—Hypoaesthesia—Carmustine—malignant glioma	0.00256	0.00627	CcSEcCtD
Trazodone—HRH1—telencephalon—malignant glioma	0.00255	0.00727	CbGeAlD
Trazodone—ADRA2A—telencephalon—malignant glioma	0.00251	0.00714	CbGeAlD
Trazodone—HTR1A—spinal cord—malignant glioma	0.00251	0.00714	CbGeAlD
Trazodone—Visual impairment—Carmustine—malignant glioma	0.00248	0.00607	CcSEcCtD
Trazodone—Hallucination—Temozolomide—malignant glioma	0.00247	0.00606	CcSEcCtD
Trazodone—Hypoaesthesia—Temozolomide—malignant glioma	0.00247	0.00606	CcSEcCtD
Trazodone—HTR2C—central nervous system—malignant glioma	0.00242	0.00688	CbGeAlD
Trazodone—HTR2A—brainstem—malignant glioma	0.0024	0.00684	CbGeAlD
Trazodone—Visual impairment—Temozolomide—malignant glioma	0.00239	0.00587	CcSEcCtD
Trazodone—Flushing—Carmustine—malignant glioma	0.00239	0.00585	CcSEcCtD
Trazodone—HTR2A—retina—malignant glioma	0.00232	0.0066	CbGeAlD
Trazodone—Tinnitus—Temozolomide—malignant glioma	0.00232	0.00567	CcSEcCtD
Trazodone—Flushing—Temozolomide—malignant glioma	0.00231	0.00565	CcSEcCtD
Trazodone—Arrhythmia—Carmustine—malignant glioma	0.0023	0.00563	CcSEcCtD
Trazodone—SLC6A4—central nervous system—malignant glioma	0.00229	0.00652	CbGeAlD
Trazodone—Alopecia—Carmustine—malignant glioma	0.00227	0.00557	CcSEcCtD
Trazodone—HTR2B—central nervous system—malignant glioma	0.00227	0.00646	CbGeAlD
Trazodone—Chills—Temozolomide—malignant glioma	0.00223	0.00546	CcSEcCtD
Trazodone—Domperidone—CYP2B6—malignant glioma	0.00221	0.0831	CrCbGaD
Trazodone—Alopecia—Temozolomide—malignant glioma	0.00219	0.00538	CcSEcCtD
Trazodone—CYP2D6—brainstem—malignant glioma	0.00219	0.00623	CbGeAlD
Trazodone—Back pain—Carmustine—malignant glioma	0.00216	0.0053	CcSEcCtD
Trazodone—HTR2A—telencephalon—malignant glioma	0.00213	0.00607	CbGeAlD
Trazodone—Dysgeusia—Temozolomide—malignant glioma	0.00212	0.00519	CcSEcCtD
Trazodone—Vision blurred—Carmustine—malignant glioma	0.00211	0.00517	CcSEcCtD
Trazodone—Tremor—Carmustine—malignant glioma	0.0021	0.00514	CcSEcCtD
Trazodone—Back pain—Temozolomide—malignant glioma	0.00209	0.00512	CcSEcCtD
Trazodone—Anaemia—Carmustine—malignant glioma	0.00207	0.00507	CcSEcCtD
Trazodone—Agitation—Carmustine—malignant glioma	0.00206	0.00504	CcSEcCtD
Trazodone—Vision blurred—Temozolomide—malignant glioma	0.00204	0.00499	CcSEcCtD
Trazodone—HTR1A—central nervous system—malignant glioma	0.00203	0.00579	CbGeAlD
Trazodone—Tremor—Temozolomide—malignant glioma	0.00203	0.00496	CcSEcCtD
Trazodone—Ill-defined disorder—Temozolomide—malignant glioma	0.00201	0.00492	CcSEcCtD
Trazodone—Anaemia—Temozolomide—malignant glioma	0.002	0.0049	CcSEcCtD
Trazodone—Agitation—Temozolomide—malignant glioma	0.00199	0.00487	CcSEcCtD
Trazodone—HTR1A—cerebellum—malignant glioma	0.00199	0.00566	CbGeAlD
Trazodone—ADRA2A—medulla oblongata—malignant glioma	0.00197	0.00561	CbGeAlD
Trazodone—Malaise—Temozolomide—malignant glioma	0.00195	0.00478	CcSEcCtD
Trazodone—Vertigo—Temozolomide—malignant glioma	0.00194	0.00476	CcSEcCtD
Trazodone—CYP2D6—telencephalon—malignant glioma	0.00194	0.00553	CbGeAlD
Trazodone—Hypertension—Carmustine—malignant glioma	0.00193	0.00473	CcSEcCtD
Trazodone—HTR2C—brain—malignant glioma	0.00192	0.00546	CbGeAlD
Trazodone—Palpitations—Temozolomide—malignant glioma	0.00191	0.00468	CcSEcCtD
Trazodone—Chest pain—Carmustine—malignant glioma	0.0019	0.00467	CcSEcCtD
Trazodone—Myalgia—Carmustine—malignant glioma	0.0019	0.00467	CcSEcCtD
Trazodone—Anxiety—Carmustine—malignant glioma	0.0019	0.00465	CcSEcCtD
Trazodone—ADRA1A—central nervous system—malignant glioma	0.00187	0.00534	CbGeAlD
Trazodone—Hypertension—Temozolomide—malignant glioma	0.00187	0.00457	CcSEcCtD
Trazodone—Confusional state—Carmustine—malignant glioma	0.00184	0.00451	CcSEcCtD
Trazodone—Myalgia—Temozolomide—malignant glioma	0.00184	0.00451	CcSEcCtD
Trazodone—Arthralgia—Temozolomide—malignant glioma	0.00184	0.00451	CcSEcCtD
Trazodone—Anxiety—Temozolomide—malignant glioma	0.00183	0.0045	CcSEcCtD
Trazodone—ADRA1A—cerebellum—malignant glioma	0.00183	0.00522	CbGeAlD
Trazodone—Oedema—Carmustine—malignant glioma	0.00183	0.00447	CcSEcCtD
Trazodone—Discomfort—Temozolomide—malignant glioma	0.00182	0.00446	CcSEcCtD
Trazodone—SLC6A4—brain—malignant glioma	0.00182	0.00518	CbGeAlD
Trazodone—HTR2B—brain—malignant glioma	0.0018	0.00513	CbGeAlD
Trazodone—Dry mouth—Temozolomide—malignant glioma	0.0018	0.00441	CcSEcCtD
Trazodone—ADRA2A—midbrain—malignant glioma	0.0018	0.00513	CbGeAlD
Trazodone—Tachycardia—Carmustine—malignant glioma	0.00178	0.00437	CcSEcCtD
Trazodone—Confusional state—Temozolomide—malignant glioma	0.00178	0.00436	CcSEcCtD
Trazodone—Oedema—Temozolomide—malignant glioma	0.00176	0.00432	CcSEcCtD
Trazodone—ADRA2A—spinal cord—malignant glioma	0.00176	0.005	CbGeAlD
Trazodone—Anorexia—Carmustine—malignant glioma	0.00174	0.00427	CcSEcCtD
Trazodone—ABCB1—embryo—malignant glioma	0.00172	0.00489	CbGeAlD
Trazodone—Hypotension—Carmustine—malignant glioma	0.00171	0.00418	CcSEcCtD
Trazodone—Hyperhidrosis—Temozolomide—malignant glioma	0.00171	0.00418	CcSEcCtD
Trazodone—Anorexia—Temozolomide—malignant glioma	0.00168	0.00412	CcSEcCtD
Trazodone—HTR2A—medulla oblongata—malignant glioma	0.00167	0.00477	CbGeAlD
Trazodone—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00166	0.00408	CcSEcCtD
Trazodone—Insomnia—Carmustine—malignant glioma	0.00165	0.00405	CcSEcCtD
Trazodone—Paraesthesia—Carmustine—malignant glioma	0.00164	0.00402	CcSEcCtD
Trazodone—Dyspnoea—Carmustine—malignant glioma	0.00163	0.00399	CcSEcCtD
Trazodone—Somnolence—Carmustine—malignant glioma	0.00162	0.00398	CcSEcCtD
Trazodone—HTR1A—brain—malignant glioma	0.00161	0.0046	CbGeAlD
Trazodone—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00161	0.00394	CcSEcCtD
Trazodone—Insomnia—Temozolomide—malignant glioma	0.0016	0.00391	CcSEcCtD
Trazodone—Decreased appetite—Carmustine—malignant glioma	0.00159	0.00389	CcSEcCtD
Trazodone—Paraesthesia—Temozolomide—malignant glioma	0.00158	0.00388	CcSEcCtD
Trazodone—Dyspnoea—Temozolomide—malignant glioma	0.00157	0.00386	CcSEcCtD
Trazodone—Somnolence—Temozolomide—malignant glioma	0.00157	0.00384	CcSEcCtD
Trazodone—Nefazodone—SLC6A3—malignant glioma	0.00157	0.0588	CrCbGaD
Trazodone—Constipation—Carmustine—malignant glioma	0.00156	0.00383	CcSEcCtD
Trazodone—Pain—Carmustine—malignant glioma	0.00156	0.00383	CcSEcCtD
Trazodone—Decreased appetite—Temozolomide—malignant glioma	0.00153	0.00376	CcSEcCtD
Trazodone—HTR2A—midbrain—malignant glioma	0.00153	0.00436	CbGeAlD
Trazodone—Fatigue—Temozolomide—malignant glioma	0.00152	0.00373	CcSEcCtD
Trazodone—ABCB1—retina—malignant glioma	0.00152	0.00433	CbGeAlD
Trazodone—Pain—Temozolomide—malignant glioma	0.00151	0.0037	CcSEcCtD
Trazodone—Constipation—Temozolomide—malignant glioma	0.00151	0.0037	CcSEcCtD
Trazodone—Feeling abnormal—Carmustine—malignant glioma	0.0015	0.00369	CcSEcCtD
Trazodone—HTR2A—spinal cord—malignant glioma	0.00149	0.00425	CbGeAlD
Trazodone—Gastrointestinal pain—Carmustine—malignant glioma	0.00149	0.00366	CcSEcCtD
Trazodone—ADRA1A—brain—malignant glioma	0.00149	0.00424	CbGeAlD
Trazodone—Perphenazine—CYP2C18—malignant glioma	0.00147	0.0551	CrCbGaD
Trazodone—Feeling abnormal—Temozolomide—malignant glioma	0.00145	0.00356	CcSEcCtD
Trazodone—HRH1—central nervous system—malignant glioma	0.00145	0.00413	CbGeAlD
Trazodone—Abdominal pain—Carmustine—malignant glioma	0.00144	0.00354	CcSEcCtD
Trazodone—Body temperature increased—Carmustine—malignant glioma	0.00144	0.00354	CcSEcCtD
Trazodone—Gastrointestinal pain—Temozolomide—malignant glioma	0.00144	0.00354	CcSEcCtD
Trazodone—ADRA2A—central nervous system—malignant glioma	0.00142	0.00406	CbGeAlD
Trazodone—Urticaria—Temozolomide—malignant glioma	0.0014	0.00344	CcSEcCtD
Trazodone—ABCB1—telencephalon—malignant glioma	0.0014	0.00398	CbGeAlD
Trazodone—Body temperature increased—Temozolomide—malignant glioma	0.0014	0.00342	CcSEcCtD
Trazodone—Abdominal pain—Temozolomide—malignant glioma	0.0014	0.00342	CcSEcCtD
Trazodone—ADRA2A—cerebellum—malignant glioma	0.00139	0.00397	CbGeAlD
Trazodone—Hypersensitivity—Carmustine—malignant glioma	0.00135	0.0033	CcSEcCtD
Trazodone—Asthenia—Carmustine—malignant glioma	0.00131	0.00321	CcSEcCtD
Trazodone—Hypersensitivity—Temozolomide—malignant glioma	0.0013	0.00319	CcSEcCtD
Trazodone—Asthenia—Temozolomide—malignant glioma	0.00127	0.0031	CcSEcCtD
Trazodone—Diarrhoea—Carmustine—malignant glioma	0.00125	0.00306	CcSEcCtD
Trazodone—Pruritus—Temozolomide—malignant glioma	0.00125	0.00306	CcSEcCtD
Trazodone—HTR2A—central nervous system—malignant glioma	0.00121	0.00345	CbGeAlD
Trazodone—Dizziness—Carmustine—malignant glioma	0.00121	0.00296	CcSEcCtD
Trazodone—Diarrhoea—Temozolomide—malignant glioma	0.00121	0.00296	CcSEcCtD
Trazodone—HTR2A—cerebellum—malignant glioma	0.00118	0.00337	CbGeAlD
Trazodone—Dizziness—Temozolomide—malignant glioma	0.00117	0.00286	CcSEcCtD
Trazodone—Vomiting—Carmustine—malignant glioma	0.00116	0.00284	CcSEcCtD
Trazodone—HRH1—brain—malignant glioma	0.00115	0.00328	CbGeAlD
Trazodone—Rash—Carmustine—malignant glioma	0.00115	0.00282	CcSEcCtD
Trazodone—Dermatitis—Carmustine—malignant glioma	0.00115	0.00282	CcSEcCtD
Trazodone—Headache—Carmustine—malignant glioma	0.00114	0.0028	CcSEcCtD
Trazodone—ADRA2A—brain—malignant glioma	0.00113	0.00322	CbGeAlD
Trazodone—Vomiting—Temozolomide—malignant glioma	0.00112	0.00275	CcSEcCtD
Trazodone—CYP3A4—central nervous system—malignant glioma	0.00112	0.0032	CbGeAlD
Trazodone—Rash—Temozolomide—malignant glioma	0.00111	0.00273	CcSEcCtD
Trazodone—Dermatitis—Temozolomide—malignant glioma	0.00111	0.00272	CcSEcCtD
Trazodone—Headache—Temozolomide—malignant glioma	0.00111	0.00271	CcSEcCtD
Trazodone—CYP2D6—central nervous system—malignant glioma	0.0011	0.00314	CbGeAlD
Trazodone—ABCB1—medulla oblongata—malignant glioma	0.0011	0.00313	CbGeAlD
Trazodone—Perphenazine—CYP2B6—malignant glioma	0.00109	0.0409	CrCbGaD
Trazodone—Nausea—Carmustine—malignant glioma	0.00108	0.00266	CcSEcCtD
Trazodone—CYP2D6—cerebellum—malignant glioma	0.00108	0.00307	CbGeAlD
Trazodone—Nausea—Temozolomide—malignant glioma	0.00105	0.00257	CcSEcCtD
Trazodone—ABCB1—midbrain—malignant glioma	0.001	0.00286	CbGeAlD
Trazodone—ABCB1—spinal cord—malignant glioma	0.000979	0.00279	CbGeAlD
Trazodone—HTR2A—brain—malignant glioma	0.000962	0.00274	CbGeAlD
Trazodone—Loxapine—SLC6A3—malignant glioma	0.000932	0.035	CrCbGaD
Trazodone—CYP2D6—brain—malignant glioma	0.000876	0.0025	CbGeAlD
Trazodone—ABCB1—central nervous system—malignant glioma	0.000794	0.00226	CbGeAlD
Trazodone—ABCB1—cerebellum—malignant glioma	0.000776	0.00221	CbGeAlD
Trazodone—ABCB1—brain—malignant glioma	0.00063	0.0018	CbGeAlD
Trazodone—ABCB1—Metabolism—NCOR1—malignant glioma	2.53e-05	0.000118	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PIK3CD—malignant glioma	2.52e-05	0.000118	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CAT—malignant glioma	2.52e-05	0.000118	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—BAD—malignant glioma	2.52e-05	0.000118	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—PIK3CA—malignant glioma	2.51e-05	0.000117	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—CASP3—malignant glioma	2.51e-05	0.000117	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—IL2—malignant glioma	2.5e-05	0.000117	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—PIK3CA—malignant glioma	2.5e-05	0.000117	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CD80—malignant glioma	2.5e-05	0.000117	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—NOTCH1—malignant glioma	2.5e-05	0.000116	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—APC—malignant glioma	2.49e-05	0.000116	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3CG—malignant glioma	2.49e-05	0.000116	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CD80—malignant glioma	2.49e-05	0.000116	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CAV1—malignant glioma	2.49e-05	0.000116	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3CG—malignant glioma	2.49e-05	0.000116	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—APC—malignant glioma	2.49e-05	0.000116	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.49e-05	0.000116	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—KRAS—malignant glioma	2.48e-05	0.000116	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—KRAS—malignant glioma	2.47e-05	0.000115	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EGF—malignant glioma	2.46e-05	0.000115	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—KDR—malignant glioma	2.46e-05	0.000115	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EGF—malignant glioma	2.46e-05	0.000115	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTPN11—malignant glioma	2.45e-05	0.000114	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CD80—malignant glioma	2.45e-05	0.000114	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTPN11—malignant glioma	2.44e-05	0.000114	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTT1—malignant glioma	2.44e-05	0.000114	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—APC—malignant glioma	2.44e-05	0.000114	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3CG—malignant glioma	2.44e-05	0.000114	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—FGF2—malignant glioma	2.43e-05	0.000113	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—FGF2—malignant glioma	2.42e-05	0.000113	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EGF—malignant glioma	2.41e-05	0.000113	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PPARG—malignant glioma	2.4e-05	0.000112	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTPN11—malignant glioma	2.4e-05	0.000112	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PIK3CD—malignant glioma	2.38e-05	0.000111	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—NCOR1—malignant glioma	2.38e-05	0.000111	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MMP9—malignant glioma	2.37e-05	0.000111	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—FN1—malignant glioma	2.37e-05	0.000111	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—F2—malignant glioma	2.37e-05	0.000111	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PTEN—malignant glioma	2.36e-05	0.00011	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—BRAF—malignant glioma	2.34e-05	0.000109	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—BAD—malignant glioma	2.34e-05	0.000109	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—BRAF—malignant glioma	2.34e-05	0.000109	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—NOTCH1—malignant glioma	2.32e-05	0.000108	CbGpPWpGaD
Trazodone—HTR2B—Signaling by GPCR—AKT1—malignant glioma	2.3e-05	0.000107	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—BRAF—malignant glioma	2.29e-05	0.000107	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS1—malignant glioma	2.29e-05	0.000107	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—PIK3CA—malignant glioma	2.28e-05	0.000106	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AKT2—malignant glioma	2.28e-05	0.000106	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PTEN—malignant glioma	2.28e-05	0.000106	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AKT2—malignant glioma	2.28e-05	0.000106	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MDM2—malignant glioma	2.27e-05	0.000106	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CD80—malignant glioma	2.27e-05	0.000106	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—EGFR—malignant glioma	2.27e-05	0.000106	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—PIK3CA—malignant glioma	2.27e-05	0.000106	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CG—malignant glioma	2.27e-05	0.000106	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—APC—malignant glioma	2.27e-05	0.000106	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—EGFR—malignant glioma	2.27e-05	0.000106	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—RAF1—malignant glioma	2.26e-05	0.000106	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MDM2—malignant glioma	2.26e-05	0.000106	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—RAF1—malignant glioma	2.25e-05	0.000105	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EGF—malignant glioma	2.24e-05	0.000105	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—ERBB2—malignant glioma	2.24e-05	0.000105	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AKT2—malignant glioma	2.23e-05	0.000104	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—ERBB2—malignant glioma	2.23e-05	0.000104	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTPN11—malignant glioma	2.23e-05	0.000104	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—EGFR—malignant glioma	2.22e-05	0.000104	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PIK3CB—malignant glioma	2.21e-05	0.000103	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PIK3CB—malignant glioma	2.2e-05	0.000103	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3CD—malignant glioma	2.19e-05	0.000102	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3CD—malignant glioma	2.19e-05	0.000102	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3CD—malignant glioma	2.18e-05	0.000102	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—PIK3CA—malignant glioma	2.17e-05	0.000101	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—PIK3CA—malignant glioma	2.17e-05	0.000101	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3CD—malignant glioma	2.15e-05	0.0001	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—KRAS—malignant glioma	2.15e-05	0.0001	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—KRAS—malignant glioma	2.14e-05	9.99e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—BRAF—malignant glioma	2.13e-05	9.95e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—BCHE—malignant glioma	2.13e-05	9.93e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—VEGFA—malignant glioma	2.13e-05	9.93e-05	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—PIK3CA—malignant glioma	2.13e-05	9.92e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CXCL8—malignant glioma	2.12e-05	9.92e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CXCL8—malignant glioma	2.11e-05	9.86e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—STAT3—malignant glioma	2.11e-05	9.83e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—SLC5A5—malignant glioma	2.1e-05	9.81e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—KRAS—malignant glioma	2.1e-05	9.8e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—FGF2—malignant glioma	2.1e-05	9.79e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—FGF2—malignant glioma	2.09e-05	9.77e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PIK3CB—malignant glioma	2.08e-05	9.7e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AKT2—malignant glioma	2.07e-05	9.68e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—EGFR—malignant glioma	2.07e-05	9.64e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTGS2—malignant glioma	2.06e-05	9.61e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—CAV1—malignant glioma	2.06e-05	9.61e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—FGF2—malignant glioma	2.05e-05	9.59e-05	CbGpPWpGaD
Trazodone—HTR1A—GPCR downstream signaling—AKT1—malignant glioma	2.05e-05	9.58e-05	CbGpPWpGaD
Trazodone—HTR2C—GPCR downstream signaling—AKT1—malignant glioma	2.04e-05	9.53e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—CASP3—malignant glioma	2.03e-05	9.49e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—IL2—malignant glioma	2.03e-05	9.48e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—CASP3—malignant glioma	2.02e-05	9.44e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—IL2—malignant glioma	2.02e-05	9.43e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CD—malignant glioma	1.99e-05	9.3e-05	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—PIK3CA—malignant glioma	1.97e-05	9.22e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—PIK3CA—malignant glioma	1.97e-05	9.2e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—PIK3CA—malignant glioma	1.97e-05	9.18e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MDM2—malignant glioma	1.96e-05	9.16e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MDM2—malignant glioma	1.96e-05	9.14e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—MYC—malignant glioma	1.96e-05	9.14e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—RAF1—malignant glioma	1.96e-05	9.13e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—RAF1—malignant glioma	1.95e-05	9.11e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—KRAS—malignant glioma	1.95e-05	9.11e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—CAV1—malignant glioma	1.94e-05	9.06e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—ERBB2—malignant glioma	1.94e-05	9.03e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—ERBB2—malignant glioma	1.93e-05	9.01e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—PIK3CA—malignant glioma	1.93e-05	9.01e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MDM2—malignant glioma	1.92e-05	8.97e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MMP9—malignant glioma	1.92e-05	8.97e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—RAF1—malignant glioma	1.92e-05	8.94e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—EGFR—malignant glioma	1.91e-05	8.94e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MMP9—malignant glioma	1.91e-05	8.92e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PTEN—malignant glioma	1.91e-05	8.92e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3CB—malignant glioma	1.91e-05	8.91e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—FGF2—malignant glioma	1.91e-05	8.91e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3CB—malignant glioma	1.91e-05	8.9e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.9e-05	8.89e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PTEN—malignant glioma	1.9e-05	8.87e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—ERBB2—malignant glioma	1.9e-05	8.85e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTGS2—malignant glioma	1.89e-05	8.81e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CG—malignant glioma	1.88e-05	8.75e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3CB—malignant glioma	1.87e-05	8.73e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling by GPCR—AKT1—malignant glioma	1.86e-05	8.7e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling by GPCR—AKT1—malignant glioma	1.85e-05	8.65e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CXCL8—malignant glioma	1.84e-05	8.57e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CXCL8—malignant glioma	1.83e-05	8.55e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PPARG—malignant glioma	1.81e-05	8.45e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—KRAS—malignant glioma	1.81e-05	8.44e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CXCL8—malignant glioma	1.8e-05	8.39e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PTEN—malignant glioma	1.8e-05	8.38e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—PIK3CA—malignant glioma	1.79e-05	8.37e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MDM2—malignant glioma	1.79e-05	8.34e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—RAF1—malignant glioma	1.78e-05	8.31e-05	CbGpPWpGaD
Trazodone—HTR2A—GPCR downstream signaling—AKT1—malignant glioma	1.77e-05	8.28e-05	CbGpPWpGaD
Trazodone—HRH1—GPCR downstream signaling—AKT1—malignant glioma	1.77e-05	8.26e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.77e-05	8.25e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—ERBB2—malignant glioma	1.76e-05	8.22e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—CASP3—malignant glioma	1.76e-05	8.2e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—IL2—malignant glioma	1.75e-05	8.19e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—CASP3—malignant glioma	1.75e-05	8.18e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—IL2—malignant glioma	1.75e-05	8.17e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CB—malignant glioma	1.74e-05	8.11e-05	CbGpPWpGaD
Trazodone—ADRA1A—GPCR downstream signaling—AKT1—malignant glioma	1.74e-05	8.1e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—VEGFA—malignant glioma	1.73e-05	8.05e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—CASP3—malignant glioma	1.72e-05	8.03e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—IL2—malignant glioma	1.72e-05	8.02e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—VEGFA—malignant glioma	1.72e-05	8.01e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—STAT3—malignant glioma	1.71e-05	7.97e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PPARG—malignant glioma	1.71e-05	7.96e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—STAT3—malignant glioma	1.7e-05	7.93e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—GSTP1—malignant glioma	1.69e-05	7.9e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CXCL8—malignant glioma	1.67e-05	7.79e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—PIK3CA—malignant glioma	1.66e-05	7.76e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MMP9—malignant glioma	1.66e-05	7.75e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MMP9—malignant glioma	1.66e-05	7.73e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PTEN—malignant glioma	1.65e-05	7.7e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CD—malignant glioma	1.65e-05	7.69e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CAT—malignant glioma	1.65e-05	7.69e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PTEN—malignant glioma	1.65e-05	7.69e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PTEN—malignant glioma	1.65e-05	7.68e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MMP9—malignant glioma	1.63e-05	7.59e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PTEN—malignant glioma	1.62e-05	7.54e-05	CbGpPWpGaD
Trazodone—ADRA2A—GPCR downstream signaling—AKT1—malignant glioma	1.61e-05	7.53e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling by GPCR—AKT1—malignant glioma	1.61e-05	7.51e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—TP53—malignant glioma	1.61e-05	7.5e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling by GPCR—AKT1—malignant glioma	1.61e-05	7.5e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.61e-05	7.5e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—CASP3—malignant glioma	1.6e-05	7.46e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—IL2—malignant glioma	1.6e-05	7.45e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—MYC—malignant glioma	1.59e-05	7.41e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—MYC—malignant glioma	1.58e-05	7.37e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling by GPCR—AKT1—malignant glioma	1.58e-05	7.36e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—NCOR1—malignant glioma	1.56e-05	7.26e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.55e-05	7.25e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—EGFR—malignant glioma	1.55e-05	7.25e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—EGFR—malignant glioma	1.54e-05	7.21e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MMP9—malignant glioma	1.51e-05	7.05e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PTEN—malignant glioma	1.5e-05	7.01e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—VEGFA—malignant glioma	1.49e-05	6.96e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—VEGFA—malignant glioma	1.49e-05	6.94e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—STAT3—malignant glioma	1.48e-05	6.89e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—STAT3—malignant glioma	1.47e-05	6.87e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—KRAS—malignant glioma	1.47e-05	6.85e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling by GPCR—AKT1—malignant glioma	1.46e-05	6.84e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—VEGFA—malignant glioma	1.46e-05	6.81e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—KRAS—malignant glioma	1.46e-05	6.81e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—STAT3—malignant glioma	1.45e-05	6.75e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CB—malignant glioma	1.44e-05	6.71e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTGS2—malignant glioma	1.42e-05	6.65e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—MYC—malignant glioma	1.37e-05	6.4e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—MYC—malignant glioma	1.37e-05	6.39e-05	CbGpPWpGaD
Trazodone—HTR2B—Signaling Pathways—AKT1—malignant glioma	1.36e-05	6.34e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—VEGFA—malignant glioma	1.36e-05	6.33e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.35e-05	6.32e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—PIK3CA—malignant glioma	1.35e-05	6.29e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—MYC—malignant glioma	1.34e-05	6.27e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—STAT3—malignant glioma	1.34e-05	6.27e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTGS2—malignant glioma	1.34e-05	6.26e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—EGFR—malignant glioma	1.34e-05	6.26e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—PIK3CA—malignant glioma	1.34e-05	6.26e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—EGFR—malignant glioma	1.34e-05	6.25e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—EGFR—malignant glioma	1.31e-05	6.13e-05	CbGpPWpGaD
Trazodone—CYP3A7—Metabolism—AKT1—malignant glioma	1.31e-05	6.12e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—TP53—malignant glioma	1.3e-05	6.09e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—TP53—malignant glioma	1.3e-05	6.05e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—CAV1—malignant glioma	1.27e-05	5.92e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—KRAS—malignant glioma	1.27e-05	5.91e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—PIK3CA—malignant glioma	1.27e-05	5.91e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—KRAS—malignant glioma	1.26e-05	5.9e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—MYC—malignant glioma	1.25e-05	5.82e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PTEN—malignant glioma	1.24e-05	5.8e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—KRAS—malignant glioma	1.24e-05	5.79e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—EGFR—malignant glioma	1.22e-05	5.7e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PTEN—malignant glioma	1.17e-05	5.46e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—PIK3CA—malignant glioma	1.16e-05	5.43e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—PIK3CA—malignant glioma	1.16e-05	5.42e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—PIK3CA—malignant glioma	1.16e-05	5.42e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CG—malignant glioma	1.16e-05	5.39e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—KRAS—malignant glioma	1.15e-05	5.38e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—PIK3CA—malignant glioma	1.14e-05	5.32e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—TP53—malignant glioma	1.13e-05	5.26e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—TP53—malignant glioma	1.12e-05	5.25e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PPARG—malignant glioma	1.12e-05	5.2e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—TP53—malignant glioma	1.1e-05	5.15e-05	CbGpPWpGaD
Trazodone—HTR1A—Signaling Pathways—AKT1—malignant glioma	1.1e-05	5.14e-05	CbGpPWpGaD
Trazodone—HTR2C—Signaling Pathways—AKT1—malignant glioma	1.1e-05	5.11e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—PIK3CA—malignant glioma	1.06e-05	4.94e-05	CbGpPWpGaD
Trazodone—ADRA2A—Metabolism—AKT1—malignant glioma	1.03e-05	4.83e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—TP53—malignant glioma	1.02e-05	4.78e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CD—malignant glioma	1.02e-05	4.74e-05	CbGpPWpGaD
Trazodone—HTR2A—Signaling Pathways—AKT1—malignant glioma	9.51e-06	4.44e-05	CbGpPWpGaD
Trazodone—HRH1—Signaling Pathways—AKT1—malignant glioma	9.49e-06	4.43e-05	CbGpPWpGaD
Trazodone—CYP3A5—Metabolism—AKT1—malignant glioma	9.48e-06	4.43e-05	CbGpPWpGaD
Trazodone—ADRA1A—Signaling Pathways—AKT1—malignant glioma	9.31e-06	4.35e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CB—malignant glioma	8.85e-06	4.13e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTGS2—malignant glioma	8.77e-06	4.09e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—PIK3CA—malignant glioma	8.76e-06	4.09e-05	CbGpPWpGaD
Trazodone—ADRA2A—Signaling Pathways—AKT1—malignant glioma	8.65e-06	4.04e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—PIK3CA—malignant glioma	8.25e-06	3.85e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PTEN—malignant glioma	7.65e-06	3.57e-05	CbGpPWpGaD
Trazodone—ABCB1—Metabolism—AKT1—malignant glioma	7.16e-06	3.34e-05	CbGpPWpGaD
Trazodone—CYP2D6—Metabolism—AKT1—malignant glioma	6.74e-06	3.15e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—PIK3CA—malignant glioma	5.4e-06	2.52e-05	CbGpPWpGaD
Trazodone—CYP3A4—Metabolism—AKT1—malignant glioma	4.41e-06	2.06e-05	CbGpPWpGaD
